Jul 2, 2021
This episode is an audio version of a video interview conducted by the Journal’s Editor in Chief, Dr Audiey Kao, with Dr Caleb Alexander, a Professor of Epidemiology and Medicine at Johns Hopkins Bloomberg School of Public Health, about the US Food and Drug Administration’s controversial decision to approve aducanumab for the treatment of Alzheimer’s disease.
To watch the full video interview, head to our site, JournalofEthics.org, or check out our YouTube channel.